Resolution Therapeutics

Resolution Therapeutics is owned by Syncona.

Syncona is one of the...

• FTSE 350.

Syncona is a company listed under the stock ticker SYNC (GB).

Syncona has a direct presence in 3 countries.

Syncona has 13 subsidiaries including Achilles Therapeutics, Anaveon and Autolus Therapeutics.

They are in:

• Biotechnology86%
• Holding7%
• Other7%

Acquisition, funding and merger involving Syncona.

• Syncona has announced the acquisition of Beacon Therapeutics  (posted on October 28 2022).

View the org chart displaying its 20 main executives

Most searched biographies at Resolution Therapeutics

• Amir Hefni, Chief Executive Officer
• Bill Symonds, Non-Executive Director
• Edward Hodgkin, Director

Create your alert
to follow the executive moves at Resolution Therapeutics.

Syncona has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Resolution Therapeutics

• News - Resolution Therapeutics

Social media about Resolution Therapeutics

• Resolution Therapeutics on Wikipedia, Google News & Yahoo Finance
• Resolution Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Amir Hefni

Call Resolution Therapeutics at +44 207...

View the org chart

Register to receive your alert

Report an error